Table 5.

Odds Ratios for the Prevalence of Chronic Kidney Disease (CKD) in Patients with or without Hypertension

	Model 1		Model 2		Model 3
	OR (95%) CI	P	OR (95%) CI	P	OR (95%) CI	P
Hypertensive disease (+)
AO	1.39 (0.99–1.96)	0.06	1.36 (0.95–1.94)	0.09	1.35 (0.94–1.93)	0.10
HFPG	1.66 (1.27–2.18)	<0.01	1.54 (1.16–2.04)	<0.01	1.47 (1.07–2.01)	0.02
HTG	1.26 (0.95–1.67)	0.10	1.30 (0.97–1.74)	0.08	1.32 (0.98–1.77)	0.07
LHDL-C	1.33 (0.94–1.90)	0.11	1.28 (0.88–1.86)	0.19	1.25 (0.86–1.82)	0.25
Hypertensive disease (-)
AO	1.16 (0.70–1.92)	0.56	1.06 (0.62–1.80)	0.84	1.06 (0.62–1.81)	0.83
HFPG	1.86 (1.06–3.27)	0.03	1.28 (0.70–2.33)	0.42	1.35 (0.68–2.67)	0.39
HTG	1.26 (0.72–2.19)	0.42	1.33 (0.74–2.40)	0.35	1.31 (0.72–2.37)	0.37
LHDL-C	1.61 (0.88–2.97)	0.12	1.51 (0.79–2.91)	0.22	1.53 (0.79–2.94)	0.21

Notes: Model 1 unadjusted. Model 2 adjusted for age, sex. Model 3 adjusted for age, sex, and history of taking blood pressure control drugs and blood glucose control drugs.

Abbreviations: CI, confidence interval; AO, abdominal obesity; HTG, high triacylglycerols; HFPG, high fasting plasma glucose; LHDL-C, low high-density lipoprotein cholesterol.